THIRD EXTENSION - GRANTED
granted
on 31 Oct 2024
Last Applicant/ Owned by
180 3rd Avenue, Fifth Floor
Waltham
MA
02451
Serial Number
97316737 filed on 17th Mar 2022
Registration Number
N/A
Correspondent Address
Peter Kunin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SKYSTAR
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis; pharmaceuticals used in the treatment of cancers, and other diseases, namely, cardiovas Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis; pharmaceuticals used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97316737
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 16694005UST3
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Oct 2024 | SOU EXTENSION 3 GRANTED |
| 31st Oct 2024 | SOU EXTENSION 3 FILED |
| 31st Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 31st Oct 2024 | SOU TEAS EXTENSION RECEIVED |
| 24th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 24th Jun 2024 | SOU EXTENSION 2 GRANTED |
| 24th Jun 2024 | SOU EXTENSION 2 FILED |
| 24th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 16th Mar 2024 | CORRECTED NOA E-MAILED |
| 15th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |